Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma
prnewswire.com·33m
engineering-portfolio
alessiotoniolo.com·1d
Football Daily | The good, the bad and the ugly from Premier League’s opening weekend
theguardian.com·19h
Plan E for AI Doom
lesswrong.com·1d
Indian Defense Stocks Lag as Tensions With China Ease
bloomberg.com·8h
Underdog bias rules everything around me
lesswrong.com·1d
Meme Stocks Are Back in 2025: 3 Smart Ways To Profit Now
finance.yahoo.com·1d
Via、新規公開株式実施に向け登録届出書を提出
news.jp·1d
Loading...Loading more...